uBiome is jumping into therapeutics with a healthy $83 million in Series C financing
uBiome is jumping into therapeutics with a healthy million in Series C financing 23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether your intestines carry the right kind of bacteria for healthy digestion but has since expanded to include over 250,000 samples for everything from the microbes on your skin to vaginal health — the largest data set in the world for these types of samples,…
Read More